Disease Overview：Lupus nephritis（LN）
Lupus nephritis (LN) is a serious autoimmune complication of systemic lupus erythematosus (SLE), characterized by immune complex–mediated inflammation and damage to the glomeruli, tubules, and interstitium of the kidneys. It affects approximately 30–60% of SLE patients and remains a leading cause of morbidity and mortality—particularly due to progression to end-stage kidney disease. Clinical presentation varies widely, from asymptomatic urinary abnormalities (e.g., proteinuria, microscopic hematuria) to nephrotic syndrome or rapidly progressive glomerulonephritis. Diagnosis relies on renal biopsy—the gold standard for histopathological classification (ISN/RPS system)—combined with serologic markers (anti-dsDNA, low complement C3/C4), urine analysis, and estimated glomerular filtration rate (eGFR). Treatment is stratified by histologic class and risk profile, typically involving corticosteroids, immunosuppressants (e.g., mycophenolate mofetil, cyclophosphamide), and increasingly, biologics such as belimumab or voclosporin.
China offers distinct advantages in LN management: its top-tier nephrology centers—many affiliated with universities like Peking Union Medical College Hospital and Shanghai Renji Hospital—combine deep expertise in autoimmune renal disease with advanced diagnostic capabilities, including digital pathology platforms and real-time monitoring of treatment response via urinary biomarkers (e.g., MCP-1, NGAL). Clinical outcomes align closely with international benchmarks: multi-center studies report complete renal remission rates of 55–68% at 12 months with optimized regimens. Crucially, treatment costs—including biopsy, targeted therapy, and extended follow-up—are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based protocols or multidisciplinary care. As a dedicated medical tourism agency, we facilitate seamless access for international patients: coordinating appointments with certified LN specialists, verifying hospital accreditation and physician credentials, providing itemized, transparent pricing in advance, and delivering end-to-end support—from visa assistance and medical translation to post-treatment rehabilitation coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Lupus Nephritis (Nephrology Department)
Non-Surgical / Conservative / Medication-Based Therapy
*Target Criteria:* Class III–IV LN (active proliferative), Class V with nephrotic-range proteinuria, or mixed histology with significant activity on biopsy.
- •Induction Phase (6 months)
- *Oral prednisone taper (starting 0.5–1 mg/kg/day)*: $15–$25/month - *Mycophenolate mofetil (MMF) 2–3 g/day*: $180–$240/month - *Cyclophosphamide (IV, monthly × 6)*: $220–$300/month (includes drug + infusion fee) - *Rituximab (375 mg/m² × 4 weekly doses)*: $1,400–$1,850/course
- •Maintenance Phase (≥2 years)
- *Azathioprine 2–3 mg/kg/day*: $45–$75/month - *Low-dose prednisone (≤5 mg/day)*: $8–$12/month
- •Monitoring Labs & Exams (per 3-month cycle)
- Serum creatinine, eGFR, albumin, C3/C4, anti-dsDNA: $65 - Renal ultrasound: $42 - *Total quarterly monitoring cost*: $125–$145
Surgical / Procedural / Interventional Options
*Eligibility:* Biopsy-proven active LN unresponsive to ≥6 months of standard induction; contraindications to immunosuppressants; or rapidly progressive GN with crescents >50%.
- •Renal Biopsy (Ultrasound-guided, percutaneous)
- Pre-op workup (CBC, PT/INR, renal function, coagulation panel, BP check): $95
- •Plasma Exchange (PLEX)
- Per session (1.2–1.5 plasma volumes): $280–$360 - Typical course: 5–7 sessions over 2 weeks → $1,400–$2,520
Special / Complex Condition Management
- •LN with ESRD (eGFR <15 mL/min/1.73m²)
- Peritoneal dialysis setup + monthly supplies0–$560/month
- •Pregnancy-associated LN flare
- Monthly maternal-fetal neph ultrasound:
$160–$210/visitQuick Selection Guide
- •
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Lupus nephritis Medical Vacation Packages
Curated transparent all-inclusive packages combining Lupus nephritis treatment with China top medical destinations:
